Banner

March 13, 2010

ClinPage Exclusive: Jerry Schindler

The Biostatistical Case For EDC

A discussion about infrastructure for adaptive clinical trials. With process change and the right technology, Cytel‘s Jerry Schindler says, pharma could wring significant savings out of clinical development.

thumbnail
ClinPage Exclusive: Jerry Schindler

The Biostatistical Case For EDC

January 26, 2007

By Mark Uehling

It is utterly impossible to pigeonhole Dr. Jerald Schindler. We’ve tried. Schindler confounds the three easiest caricatures that any self-respecting journalist would reach for. Schindler is a biostatistician, but speaks fluidly, lucidly. He’s a vendor, but leaves his Cytel sales pitch…

No articles available